ALFA Filings
Every announcement, straight from the exchange
Every Ishita Drugs & Industries other announcement announcement on NSE and BSE, newest first, each with its own page.
Time
5 announcements
Ishita Drugs & Industries Ltd submitted its quarterly shareholding pattern under Regulation 31, disclosing the promoter and public shareholdings as of September 30, 2026.
Ishita Drugs & Industries Ltd has re-appointed M/s. Jaymin Shah & Associates as its Statutory Auditor from the 33rd to the 34th AGM.
Ishita Drugs & Industries Ltd has issued physical letters to shareholders with weblinks for its FY 2025-26 Annual Report. The 33rd AGM is scheduled for September 30, 2026.
Ishita Drugs & Industries Ltd filed its quarterly shareholding pattern for the period ending June 30, 2026, in compliance with SEBI regulations.
Ishita Drugs & Industries Ltd informed the BSE that the Annual Secretarial Compliance Report for FY26 is not applicable. The company is exempt under Regulation 15(2) of SEBI LODR as its paid-up equity capital is Rs. 2.99 Crore and net worth is Rs. 10.78 Crore, both below the mandatory reporting thresholds.